Abstract
This paper presents the results of a study to evaluate pharmacological therapy in inflammatory diseases of maxillofacial area in outpatient and hospital settings. The study included a review of medical records for outpatients (n = 600) and hospitalized patients (n = 200) with inflammatory diseases of maxillofacial area, and questioning of the dental surgeons (n = 43) on etiology and treatment of those diseases. Identification of major pathogens and their antimicrobial susceptibility testing were also performed in a total of 107 patients (aged 18 to 63 years). The dental surgeons most frequently prescribed doxycycline in outpatient settings, and oxacillin, ampicillin, metronidazole, and lincomycin in hospitalized patients. Staphylococci, streptococci, and anaerobes were considered by dentist surgeons as the leading pathogens of inflammatory diseases of maxillofacial area. The main reported criteria for the choice of empirical antimicrobial treatments were an activity against presumptive pathogen(s) and a good tolerability. A total of 51 and 101 causative microorganisms were isolated from 30 outpatients and 77 hospitalized patients with inflammatory diseases of maxillofacial area, respectively; the most predominant pathogens were streptococci and staphylococci (depending on the clinical form of disease). All S. aureus isolates were susceptible to oxacillin, vancomycin, erythromycin, clindamycin, and ciprofloxacin.
-
1.
Шаргородский А.Г. Клиника, диагностика, лечение и профилактика воспалительных заболеваний лица и шеи: Руководство для врачей. – М., ГЭОТАР – МЕД, 2001.– 515 с.
-
2.
Halling F., Merten H.A. The bacteriologycal and clinical aspects of odontogenic soft-tissue infections. Dtsch ZahnMund-Kieferheilkd-Zentralbe 2002; 80(5):281-6.
-
3.
Jones R.N., Pfaller M.A., Cormical M.G. Infections diseases: principles and practice of antimicrobial therapy. Avery’s Drug Treatment. 4th ed. Barcelona: ADIS Press, 2007. р. 1455-515.
-
4.
Ушаков Р.В., Царев В.Н. Комплексный подход к антимикробной терапии в лечении одонтогенных гнойновоспалительных заболеваний челюстно-лицевой области. Российский стоматологический журнал 2003; (6):40-4.
-
5.
Mandell G.L., Bennett J.E., Polir R. Principles and Practice of infectious Disease. 4th ed. New York, 2005. 2803 p.
-
6.
Алексеева Ю. В. Этиологическая диагностика и оптимизация лечения воспалительных заболеваний челюстно-лицевой области на основе определения генетических маркеров микроорганизмов возбудителей: Автореф. дис. канд. мед. наук. - М., 2005. - 27 с.
-
7.
Mandell L.A., In: Mandell G.L., Bennett J.E., Raphael D., editors. Mandell, Douglas, Bennett’s principles and practice of infections diseases. 5th ed. Philadelphia: Churchill Livingston. – 2000: 306-7.
-
8.
Pocket Book of Infectious Disease Therapy. Ed. by J.G. Bartlett. Williams & Wilkins, 1998. 357 p.
-
9.
The Sanford Guide to Antimicrobial Therapy. Ed. by D.N. Gilbert, R.C. Jr. Moellering, G.M. Eliopoulos, M.A. Sande. – 35 rd ed. – New York: Antimicrobial Therapy, Inc, 2005.
-
10.
Vartian C.V., Semtimus E.S. Odontogenic infections. S Gt-Houst-Dent Soc 2000; 61(9):7-8.
-
11.
Тарасенко С.В. Клинико-микробиологическое обоснование профилактики и лечения гнойно-воспалительных заболеваний в челюстно-лицевой хирургии: Автореф. дис. д-ра мед. наук. – М., 2002. – 49с.
-
12.
Bauermeister C.-D. Mikrobiologische Diagnostik parodontaler infektionen. ZMK 2003; 12:1-2.
-
13.
Jones R.N. Resistance patterns nosocomial pathogens. Trends over the past few years. Chest 2001; 119; 397-404.
-
14.
Tacconelli E., De Angelis G., Cataldo M.A., et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008; 61:127-9.